Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapy

13 Dec 2022

Abstract excerpt

Breast cancer (BrCa) is a heterogeneous disease, which leads to unsatisfactory prognosis in females worldwide. Previous studies have proved that tumor immune microenvironment (TIME) plays crucial roles in oncogenesis, progression, and therapeutic resistance in Breast cancer. However, biomarkers related to TIME features have not been fully discovered. Proteasome activator complex subunit 2 (PSME2) is a member of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36583022
DOI: 10.3389/fgene.2022.1071270

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapyPMID 36583022Read ↗

MAP3K1 mutations confer tumor immune heterogeneity in hormone receptor–positive HER2-negative breast cancerSemantic proximity Read ↗

SARS-CoV-2 receptor ACE2 identifies immuno-hot tumors in breast cancerSemantic proximity Read ↗

Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures.Semantic proximity Read ↗

<i>HspA1B</i> Is a Prognostic Biomarker and Correlated With Immune Infiltrates in different subtypes of Breast CancersSemantic proximity Read ↗

Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancerSemantic proximity Read ↗

Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast CancerSemantic proximity Read ↗

The tumor immune microenvironment of primary and metastatic HER2− positive breast cancers utilizing gene expression and spatial proteomic profilingSemantic proximity Read ↗

The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profilingSemantic proximity Read ↗

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor MicroenvironmentSemantic proximity Read ↗

Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypesSemantic proximity Read ↗

The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer SubtypesSemantic proximity Read ↗

UBE2A as a prognostic indicator across human cancers: Insights from multi‑omics and immune landscape analysesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.